Cancer Signaling Transcriptome Is Upregulated in Type 2 Diabetes Mellitus

Area of Science:

• Genomics
• Molecular Biology
• Immunology

Background:

• Type 2 Diabetes (T2D) is a global health concern, particularly in the elderly.
• Understanding the molecular underpinnings of T2D in older adults is crucial for targeted interventions.
• Transcriptome analysis offers insights into cellular function and disease mechanisms.

Purpose of the Study:

• To investigate differences in whole transcriptome gene expression of peripheral blood mononuclear cells (PBMCs) between elderly individuals with and without T2D.
• To identify specific biological pathways and functions associated with T2D at the transcriptional level in this population.

Main Methods:

• Microarray-based transcriptome analysis of PBMCs from 19 elderly individuals with T2D and 15 without.
• Differential gene expression analysis using linear models.
• Functional enrichment analysis using Ingenuity Pathway Analysis (IPA) to identify significantly associated pathways.

Main Results:

• Significant associations with T2D were identified for diseases, biological functions, and canonical signaling pathways (log(Benjamini-Hochberg-adjusted p-value) > 1.30, |z-score| > 2.0).
• Cancer signaling pathways were highly upregulated in T2D patients (z-score = 2.63), encompassing 88.5% of differentially expressed genes.
• Specific upregulated pathways included integrin and paxillin signaling, while Rho-GDP dissociation inhibitor signaling was downregulated in T2D.

Conclusions:

• Elderly individuals with T2D exhibit altered gene expression profiles in PBMCs.
• Upregulated signaling pathways associated with neoplastic processes, T-cell activation/migration, and inflammation are characteristic of T2D in this age group.
• These findings highlight potential molecular targets for understanding and managing T2D complications in the elderly.